In VitroPrimary Human and Animal Cell-Based Blood−Brain Barrier Models as a Screening Tool in Drug Discovery
Olivier Lacombe, Orianne Videau, Delphine Chevillon et al. · Molecular Pharmaceutics · 2011
Brain penetration is characterized by its extent and rate and is influenced by drug physicochemical properties, plasma exposure, plasma and brain protein binding and BBB permeability. This raises questions related to physiology, interspecies differences and in vitro/in vivo extrapolation. We herein discuss the use of in vitro human and animal BBB model as a tool to improve CNS compound selection. These cell-based BBB models are characterized by low paracellular permeation, well-developed tight junctions and functional efflux transporters. A study of twenty drugs shows similar compound ranking between rat and human models although with a 2-fold higher permeability in rat. cLogP < 5, PSA < 120 Å, MW < 450 were confirmed as essential for CNS drugs. An in vitro/in vivo correlation in rat (R² = 0.67; P = 2 × 10⁻⁴) was highlighted when in vitro permeability and efflux were considered together with plasma exposure and free fraction. The cell-based BBB model is suitable to optimize CNS-drug selection, to study interspecies differences and then to support human brain exposure prediction.
Cited by 66 works. doi:10.1021/mp1004614
Authors
- Olivier Lacombe
- Orianne Videau
- Delphine Chevillon
- Anne-Cécile Guyot
- Christelle Contreras
- Sandrine Blondel
- Aurélie Ghettas
- Henri Bénech
- Etienne Thévenot
- Alain Pruvost
- Sébastien Bolze
- Lucie Krzaczkowski
- Colette Prévost
- Aloïse M Mabondzo
References
- Can the pharmaceutical industry reduce attrition rates?
- Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
- Drug resistance in brain diseases and the role of drug efflux transporters
- Structure−Brain Exposure Relationships
- Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology
- Expression, Up-Regulation, and Transport Activity of the Multidrug-Resistance Protein Abcg2 at the Mouse Blood-Brain Barrier
- On The Rate and Extent of Drug Delivery to the Brain
- Drug efflux transporters in the CNS
- Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport
- P-Glycoprotein and Breast Cancer Resistance Protein: Two Dominant Transporters Working Together in Limiting the Brain Penetration of Topotecan